LifeSciencePLUS, Inc., is pleased to announce that BloodSTOP® iX Absorbable Hemostat has been granted the Class III CE Mark certification for internal wounds. Already in medical markets overseas as a surface wound hemostat, BloodSTOP® iX will now be offered to the internal, surgical market in Europe.
Recent Posts
- Potential New Application for BloodSTOP® iX in Neurosurgical CSF Leakage Management
- Jacobi Burn Center Highlights Clinical Success with BloodSTOP iX at ABA Annual Meeting
- LifeScience PLUS Announces Publication on Revolutionary eCMC Technology in The Journal of Burn Care and Research
- America’s Lifeblood is in Crisis: A Novel Hemostatic Dressing Provides Hope
- Bleeding Out